These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 37902006)

  • 41. Correlation of Performance Status and Neutrophil-Lymphocyte Ratio with Efficacy in Radioiodine-Refractory Differentiated Thyroid Cancer Treated with Lenvatinib.
    Taylor MH; Takahashi S; Capdevila J; Tahara M; Leboulleux S; Kiyota N; Dutcus CE; Xie R; Robinson B; Sherman S; Habra MA; Elisei R; Wirth LJ
    Thyroid; 2021 Aug; 31(8):1226-1234. PubMed ID: 33637020
    [No Abstract]   [Full Text] [Related]  

  • 42. Prognostic Significance of Preoperative Lymphocyte-to-C-Reactive Protein Ratio in Patients with Non-Metastatic Colorectal Cancer.
    Ou W; Zhou C; Zhu X; Lin L; Xu Q
    Onco Targets Ther; 2021; 14():337-346. PubMed ID: 33469310
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Prognostic Value of the C-Reactive Protein/Albumin Ratio and Systemic Immune-Inflammation Index for Patients With Colorectal Liver Metastasis Undergoing Curative Resection.
    Deng Y; Zhao Y; Qin J; Huang X; Wu R; Zhou C; Pan Z
    Pathol Oncol Res; 2021; 27():633480. PubMed ID: 34257601
    [No Abstract]   [Full Text] [Related]  

  • 44. Handgrip weakness, systemic inflammation indicators, and overall survival in lung cancer patients with well performance status: A large multicenter observational study.
    Song M; Zhang Q; Song C; Liu T; Zhang X; Ruan G; Tang M; Zhang X; Xie H; Zhang H; Ge Y; Li X; Zhang K; Yang M; Li Q; Liu X; Lin S; Xu Y; Li B; Li X; Wang K; Xu H; Li W; Shi H
    Cancer Med; 2023 Feb; 12(3):2818-2830. PubMed ID: 36073671
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Comparison of selected inflammation-based prognostic markers in relapsed or refractory metastatic colorectal cancer patients.
    Song A; Eo W; Lee S
    World J Gastroenterol; 2015 Nov; 21(43):12410-20. PubMed ID: 26604648
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The prognostic role of systemic inflammation in patients undergoing resection of colorectal liver metastases: C-reactive protein (CRP) is a strong negative prognostic biomarker.
    Køstner AH; Kersten C; Löwenmark T; Ydsten KA; Peltonen R; Isoniemi H; Haglund C; Gunnarsson U; Isaksson B
    J Surg Oncol; 2016 Dec; 114(7):895-899. PubMed ID: 27696432
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Predictive value of Glasgow prognostic score in patients with colorectal cancer undergoing laparoscopic radical resection].
    Cao X; Yu T; Zhao G; Xiao G
    Zhonghua Wei Chang Wai Ke Za Zhi; 2016 Oct; 19(10):1133-1138. PubMed ID: 27781250
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The Eastern Cooperative Oncology Group Performance Status as a prognostic factor of stage I-III colorectal cancer surgery for elderly patients: a multi-institutional retrospective analysis.
    Hanaoka M; Hino H; Shiomi A; Kagawa H; Manabe S; Yamaoka Y; Kato S; Yamauchi S; Kinugasa Y; Sugihara K
    Surg Today; 2022 Jul; 52(7):1081-1089. PubMed ID: 35039939
    [TBL] [Abstract][Full Text] [Related]  

  • 49. High systemic immune-inflammation index is a predictor of poor prognosis in patients with nonsmall cell lung cancer and bone metastasis.
    Xu S; Cao S; Yu Y
    J Cancer Res Ther; 2021 Dec; 17(7):1636-1642. PubMed ID: 35381733
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Can Albumin Bilirubin Ratio and Inflammatory Prognostic Index Be A New Marker Determining Survival in Metastatic Pancreatic Cancer?
    Ekinci F; Sarı D; Çelik C; Dirican A; Erdoğan AP; Gökse G
    Gulf J Oncolog; 2021 May; 1(36):45-52. PubMed ID: 35017135
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Association of Systemic Inflammation and Sarcopenia With Survival in Nonmetastatic Colorectal Cancer: Results From the C SCANS Study.
    Feliciano EMC; Kroenke CH; Meyerhardt JA; Prado CM; Bradshaw PT; Kwan ML; Xiao J; Alexeeff S; Corley D; Weltzien E; Castillo AL; Caan BJ
    JAMA Oncol; 2017 Dec; 3(12):e172319. PubMed ID: 28796857
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Prognostic Value of Baseline ALBI Score Among Patients With Colorectal Liver Metastases: A Pooled Analysis of Two Randomized Trials.
    Abdel-Rahman O
    Clin Colorectal Cancer; 2019 Mar; 18(1):e61-e68. PubMed ID: 30348618
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Association of Systemic Inflammation and Overall Survival in Elderly Patients with Cancer Cachexia - Results from a Multicenter Study.
    Ruan GT; Yang M; Zhang XW; Song MM; Hu CL; Ge YZ; Xie HL; Liu T; Tang M; Zhang Q; Zhang X; Zhang KP; Li XR; Li QQ; Chen YB; Yu KY; Cong MH; Wang KH; Shi HP
    J Inflamm Res; 2021; 14():5527-5540. PubMed ID: 34737602
    [TBL] [Abstract][Full Text] [Related]  

  • 54. C-reactive protein/albumin ratio predicts survival after curative surgery in elderly patients with colorectal cancer.
    Tamai K; Okamura S; Makino S; Yamamura N; Fukuchi N; Ebisui C; Inoue A; Yano M
    Updates Surg; 2022 Feb; 74(1):153-162. PubMed ID: 33677820
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The C-reactive protein/albumin ratio, a novel inflammation-based prognostic score, predicts outcomes in patients with hepatocellular carcinoma.
    Kinoshita A; Onoda H; Imai N; Iwaku A; Oishi M; Tanaka K; Fushiya N; Koike K; Nishino H; Matsushima M
    Ann Surg Oncol; 2015 Mar; 22(3):803-10. PubMed ID: 25190127
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Hand grip strength-based cachexia index as a predictor of cancer cachexia and prognosis in patients with cancer.
    Xie H; Ruan G; Wei L; Zhang H; Ge Y; Zhang Q; Lin S; Song M; Zhang X; Liu X; Li X; Zhang K; Yang M; Tang M; Song CH; Gan J; Shi HP
    J Cachexia Sarcopenia Muscle; 2023 Feb; 14(1):382-390. PubMed ID: 36447437
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A Novel Systemic Inflammation Prognostic Score to Stratify Survival in Elderly Patients With Cancer.
    Ruan GT; Xie HL; Deng L; Ge YZ; Zhang Q; Wang ZW; Zhang X; Zhang HY; Tang M; Song MM; Zhang XW; Yang M; Pan L; Wang KH; Cong MH; Gong YZ; Wang MY; Shi HP
    Front Nutr; 2022; 9():893753. PubMed ID: 35866083
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Lymphocyte-to-C-Reactive Protein Ratio Is the Most Sensitive Inflammation-Based Prognostic Score in Patients With Unresectable Metastatic Colorectal Cancer.
    Nakamura Y; Shida D; Boku N; Yoshida T; Tanabe T; Takamizawa Y; Takashima A; Kanemitsu Y
    Dis Colon Rectum; 2021 Nov; 64(11):1331-1341. PubMed ID: 34623347
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Association of inflammatory markers with colorectal cancer incidence in the atherosclerosis risk in communities study.
    Prizment AE; Anderson KE; Visvanathan K; Folsom AR
    Cancer Epidemiol Biomarkers Prev; 2011 Feb; 20(2):297-307. PubMed ID: 21217085
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Close Relationship Between Immunological/Inflammatory Markers and Myopenia and Myosteatosis in Patients With Colorectal Cancer: A Propensity Score Matching Analysis.
    Okugawa Y; Toiyama Y; Yamamoto A; Shigemori T; Kitamura A; Ichikawa T; Ide S; Kitajima T; Fujikawa H; Yasuda H; Okita Y; Hiro J; Araki T; McMillan DC; Miki C; Kusunoki M
    JPEN J Parenter Enteral Nutr; 2019 May; 43(4):508-515. PubMed ID: 30334265
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.